# FDA Inspection 822029 - Children's Hospital of the King's Daughters - March 06, 2013

Source: https://www.keypedia.com/records/fda_inspections/childrens-hospital-of-the-kings-daughters/189ad103-bbc7-4e19-a97f-8c11ffbcef4c
Source feed: FDA_Inspections

> FDA Inspection 822029 for Children's Hospital of the King's Daughters on March 06, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 822029
- Company Name: Children's Hospital of the King's Daughters
- Inspection Date: 2013-03-06
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1221202 - 2023-10-16](https://www.keypedia.com/records/fda_inspections/childrens-hospital-of-the-kings-daughters/0a55af99-22e1-4124-b346-7d67914ee100)
- [FDA Inspection 1165295 - 2022-03-10](https://www.keypedia.com/records/fda_inspections/childrens-hospital-of-the-kings-daughters/1b24c939-fbac-4378-838e-dc436c4de6a9)
- [FDA Inspection 1165295 - 2022-03-10](https://www.keypedia.com/records/fda_inspections/childrens-hospital-of-the-kings-daughters/af0e5dd6-09e0-4a78-bfe4-bcb0eb75f13f)
- [FDA Inspection 1076876 - 2018-11-20](https://www.keypedia.com/records/fda_inspections/childrens-hospital-of-the-kings-daughters/305e5325-b904-4aef-bf9d-e39ea46913f9)
- [FDA Inspection 1005193 - 2017-02-24](https://www.keypedia.com/records/fda_inspections/childrens-hospital-of-the-kings-daughters/188231b7-6024-4c20-a4b9-9ea1edb5d53b)

Company: https://www.keypedia.com/companies/childrens-hospital-of-the-kings-daughters/3fd27c23-a346-4894-926d-7c8a50abf224

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d